Haruka Handa

823 total citations
22 papers, 564 citations indexed

About

Haruka Handa is a scholar working on Molecular Biology, Oncology and Physiology. According to data from OpenAlex, Haruka Handa has authored 22 papers receiving a total of 564 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 9 papers in Oncology and 3 papers in Physiology. Recurrent topics in Haruka Handa's work include RNA modifications and cancer (7 papers), Mitochondrial Function and Pathology (4 papers) and Ubiquitin and proteasome pathways (4 papers). Haruka Handa is often cited by papers focused on RNA modifications and cancer (7 papers), Mitochondrial Function and Pathology (4 papers) and Ubiquitin and proteasome pathways (4 papers). Haruka Handa collaborates with scholars based in Japan and Canada. Haruka Handa's co-authors include Hisataka Sabe, Shigeru Hashimoto, Ari Hashimoto, Tsukasa Oikawa, Yasuhito Onodera, Yutaro Otsuka, Hirokazu Sugino, Ayumu Yoshikawa, Takashi Yokota and Yasunori Okada and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Haruka Handa

22 papers receiving 563 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Haruka Handa Japan	13	327	179	111	97	75	22	564
Francesca Reggiani Italy	14	414 1.3×	229 1.3×	171 1.5×	150 1.5×	86 1.1×	29	745
Ada Girnita Sweden	16	563 1.7×	164 0.9×	195 1.8×	57 0.6×	51 0.7×	22	823
Trenis D. Palmer United States	12	332 1.0×	195 1.1×	93 0.8×	97 1.0×	64 0.9×	16	616
Yong-Nyun Kim South Korea	14	377 1.2×	193 1.1×	206 1.9×	64 0.7×	156 2.1×	23	732
Karl Deacon United Kingdom	12	431 1.3×	127 0.7×	115 1.0×	78 0.8×	103 1.4×	13	668
Minghai Shao China	17	282 0.9×	105 0.6×	123 1.1×	62 0.6×	49 0.7×	30	647
Yi Fu China	11	374 1.1×	63 0.4×	163 1.5×	73 0.8×	100 1.3×	20	600
Crystal M. Weyman United States	15	506 1.5×	84 0.5×	175 1.6×	75 0.8×	69 0.9×	26	658
Sandra Bien-Möller Germany	12	235 0.7×	108 0.6×	87 0.8×	52 0.5×	47 0.6×	19	403
Harika Sabbineni United States	12	344 1.1×	78 0.4×	94 0.8×	40 0.4×	66 0.9×	16	535

Countries citing papers authored by Haruka Handa

Since Specialization

Citations

This map shows the geographic impact of Haruka Handa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Haruka Handa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Haruka Handa more than expected).

Fields of papers citing papers by Haruka Handa

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Haruka Handa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Haruka Handa. The network helps show where Haruka Handa may publish in the future.

Co-authorship network of co-authors of Haruka Handa

This figure shows the co-authorship network connecting the top 25 collaborators of Haruka Handa. A scholar is included among the top collaborators of Haruka Handa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Haruka Handa. Haruka Handa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Oikawa, Tsukasa, Junya Hasegawa, Haruka Handa, et al.. (2024). p53 ensures the normal behavior and modification of G1/S-specific histone H3.1 in the nucleus. Life Science Alliance. 7(9). e202402835–e202402835. 2 indexed citations

Nakajima, Takayuki, Aya Yoshimura, Haruka Handa, et al.. (2023). Enhanced mitochondrial oxidative metabolism in peripheral blood mononuclear cells is associated with fatty liver in obese young adults. Scientific Reports. 13(1). 5203–5203. 7 indexed citations

Koizumi, Takuya, Masaya Watanabe, Takashi Yokota, et al.. (2023). Empagliflozin suppresses mitochondrial reactive oxygen species generation and mitigates the inducibility of atrial fibrillation in diabetic rats. Frontiers in Cardiovascular Medicine. 10. 1005408–1005408. 37 indexed citations

Higashi, Tsunehito, Haruka Handa, Yosuke Mai, Katsumi Maenaka, & Takashi Tadokoro. (2023). Protein kinase Cβ is involved in cigarette smoke gas phase-induced ferroptosis in J774 macrophages. Journal of Pharmacological Sciences. 153(1). 22–25. 1 indexed citations

Mazaki, Yuichi, et al.. (2023). LRRK2 is involved in the chemotaxis of neutrophils and differentiated HL-60 cells, and the inhibition of LRRK2 kinase activity increases fMLP-induced chemotactic activity. Cell Communication and Signaling. 21(1). 300–300. 3 indexed citations

Hashimoto, Ari, et al.. (2022). Orchestration of mesenchymal plasticity and immune evasiveness via rewiring of the metabolic program in pancreatic ductal adenocarcinoma. Frontiers in Oncology. 12. 1005566–1005566. 8 indexed citations

Kitai, Yuichi, Shunsuke Yamada, Ryuta Muromoto, et al.. (2022). A peptide derived from adaptor protein STAP-2 inhibits tumor progression by downregulating epidermal growth factor receptor signaling. Journal of Biological Chemistry. 299(1). 102724–102724. 5 indexed citations

Takada, Shingo, Shintaro Kinugawa, Haruka Handa, Takashi Yokota, & Hisataka Sabe. (2022). Cross-disease communication between cancer and heart failure provides a rational approach to prevention and treatment of both diseases. Frontiers in Oncology. 12. 1006322–1006322. 3 indexed citations

Tekgüç, Murat, James B. Wing, Ari Hashimoto, et al.. (2021). Arid5a Promotes Immune Evasion by Augmenting Tryptophan Metabolism and Chemokine Expression. Cancer Immunology Research. 9(8). 862–876. 21 indexed citations

10.

Furihata, Takaaki, Shingo Takada, Naoya Kakutani, et al.. (2021). Cardiac-specific loss of mitoNEET expression is linked with age-related heart failure. Communications Biology. 4(1). 138–138. 20 indexed citations

11.

Hashimoto, Shigeru, Ari Hashimoto, Akira Fukao, et al.. (2019). ARF6 and AMAP1 are major targets of KRAS and TP53 mutations to promote invasion, PD-L1 dynamics, and immune evasion of pancreatic cancer. Proceedings of the National Academy of Sciences. 116(35). 17450–17459. 102 indexed citations

12.

Otsuka, Yutaro, Tsukasa Oikawa, Shigeru Hashimoto, et al.. (2018). Frequent overexpression of AMAP1, an Arf6 effector in cell invasion, is characteristic of the MMTV-PyMT rather than the MMTV-Neu human breast cancer model. Cell Communication and Signaling. 16(1). 1–1. 35 indexed citations

13.

Handa, Haruka, Ari Hashimoto, Shigeru Hashimoto, et al.. (2018). Epithelial-specific histone modification of the miR-96/182 locus targeting AMAP1 mRNA predisposes p53 to suppress cell invasion in epithelial cells. Cell Communication and Signaling. 16(1). 94–94. 9 indexed citations

14.

Oikawa, Tsukasa, Yutaro Otsuka, Yasuhito Onodera, et al.. (2018). Necessity of p53-binding to the CDH1 locus for its expression defines two epithelial cell types differing in their integrity. Scientific Reports. 8(1). 1595–1595. 14 indexed citations

15.

Hashimoto, Ari, Shigeru Hashimoto, Hiroaki Sugino, et al.. (2016). ZEB1 induces EPB41L5 in the cancer mesenchymal program that drives ARF6-based invasion, metastasis and drug resistance. Oncogenesis. 5(9). e259–e259. 40 indexed citations

16.

Hashimoto, Shigeru, Shuji Mikami, Hirokazu Sugino, et al.. (2016). Lysophosphatidic acid activates Arf6 to promote the mesenchymal malignancy of renal cancer. Nature Communications. 7(1). 10656–10656. 80 indexed citations

17.

Handa, Haruka, Ari Hashimoto, Shigeru Hashimoto, & Hisataka Sabe. (2016). Arf6 and its ZEB1-EPB41L5 mesenchymal axis are required for both mesenchymal- and amoeboid-type invasion of cancer cells. Small GTPases. 9(5). 420–426. 7 indexed citations

18.

Hashimoto, Ari, Tsukasa Oikawa, Shigeru Hashimoto, et al.. (2016). P53- and mevalonate pathway–driven malignancies require Arf6 for metastasis and drug resistance. The Journal of Cell Biology. 213(1). 81–95. 49 indexed citations

19.

Kinoshita, Rumiko, Jin‐Min Nam, Yoichi M. Ito, et al.. (2013). Co-Overexpression of GEP100 and AMAP1 Proteins Correlates with Rapid Local Recurrence after Breast Conservative Therapy. PLoS ONE. 8(10). e76791–e76791. 17 indexed citations

20.

Menju, Toshi, Shigeru Hashimoto, Ari Hashimoto, et al.. (2011). Engagement of Overexpressed Her2 with GEP100 Induces Autonomous Invasive Activities and Provides a Biomarker for Metastases of Lung Adenocarcinoma. PLoS ONE. 6(9). e25301–e25301. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact